Harini Sarva

1.9k total citations · 1 hit paper
62 papers, 822 citations indexed

About

Harini Sarva is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Harini Sarva has authored 62 papers receiving a total of 822 indexed citations (citations by other indexed papers that have themselves been cited), including 36 papers in Neurology, 15 papers in Cellular and Molecular Neuroscience and 8 papers in Cognitive Neuroscience. Recurrent topics in Harini Sarva's work include Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (23 papers) and Genetic Neurodegenerative Diseases (10 papers). Harini Sarva is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (24 papers), Neurological disorders and treatments (23 papers) and Genetic Neurodegenerative Diseases (10 papers). Harini Sarva collaborates with scholars based in United States, Canada and United Kingdom. Harini Sarva's co-authors include William Severt, Andres Deik, Claire Henchcliffe, Aman Ullah, Vicki Shanker, J. Levi Chazen, Fei Wang, Cao Xiao, Jian Liang and Yize Zhao and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Harini Sarva

58 papers receiving 809 citations

Hit Papers

Phase I trial of hES cell-derived dopaminergic neurons fo... 2025 2026 2025 5 10 15 20 25

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Harini Sarva United States 15 398 138 105 104 96 62 822
Farwa Ali United States 18 518 1.3× 118 0.9× 94 0.9× 86 0.8× 59 0.6× 85 808
Meredith Spindler United States 15 488 1.2× 107 0.8× 161 1.5× 106 1.0× 36 0.4× 38 772
João Santos Pereira Brazil 18 392 1.0× 117 0.8× 122 1.2× 70 0.7× 89 0.9× 77 751
Deepak Gupta United States 13 192 0.5× 107 0.8× 50 0.5× 63 0.6× 140 1.5× 33 607
Liana S. Rosenthal United States 16 549 1.4× 259 1.9× 107 1.0× 117 1.1× 154 1.6× 63 810
Shuai Zhao China 15 145 0.4× 70 0.5× 79 0.8× 96 0.9× 154 1.6× 40 674
Verónica Puertas‐Martín Spain 19 355 0.9× 102 0.7× 261 2.5× 134 1.3× 73 0.8× 40 869
Ruth B. Schneider United States 14 478 1.2× 95 0.7× 139 1.3× 131 1.3× 63 0.7× 33 889
Meng‐Hsiang Chen Taiwan 18 295 0.7× 69 0.5× 98 0.9× 141 1.4× 88 0.9× 51 797
Stephen Barron Israel 15 207 0.5× 106 0.8× 104 1.0× 135 1.3× 72 0.8× 30 785

Countries citing papers authored by Harini Sarva

Since Specialization
Citations

This map shows the geographic impact of Harini Sarva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harini Sarva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harini Sarva more than expected).

Fields of papers citing papers by Harini Sarva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Harini Sarva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harini Sarva. The network helps show where Harini Sarva may publish in the future.

Co-authorship network of co-authors of Harini Sarva

This figure shows the co-authorship network connecting the top 25 collaborators of Harini Sarva. A scholar is included among the top collaborators of Harini Sarva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Harini Sarva. Harini Sarva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tabar, Viviane, Harini Sarva, Andrés M. Lozano, et al.. (2025). Phase I trial of hES cell-derived dopaminergic neurons for Parkinson’s disease. Nature. 641(8064). 978–983. 25 indexed citations breakdown →
2.
Sarva, Harini, et al.. (2024). Pearls and pitfalls in letters of recommendation for neurology residency applications. Journal of the Neurological Sciences. 459. 122951–122951. 1 indexed citations
3.
Fasano, Alfonso, Claire Henchcliffe, Harini Sarva, et al.. (2024). Safety, Tolerability, and Clinical Assessment of Bemdaneprocel for Parkinson’s Disease: 18-Month Results From a Phase 1 Study. Parkinsonism & Related Disorders. 122. 106129–106129.
4.
Tabar, Viviane, Kenny Kwok Hei Yu, Andrés M. Lozano, et al.. (2024). 510 Dopaminergic Neuronal Cell Therapy for Parkinson’s Disease: Results From a Phase 1 Study of Bemdaneprocel. Neurosurgery. 70(Supplement_1). 156–156. 1 indexed citations
5.
Sarva, Harini, et al.. (2024). The role of genetics in the treatment of dystonia with deep brain stimulation: Systematic review and Meta-analysis. Journal of the Neurological Sciences. 459. 122970–122970. 1 indexed citations
6.
Rodríguez‐Porcel, Federico, Harini Sarva, Juho Joutsa, et al.. (2024). Current opinions and practices in post-stroke movement disorders: Survey of movement disorders society members. Journal of the Neurological Sciences. 458. 122925–122925.
7.
Zolin, Aryeh, et al.. (2023). Dystonia phenomenology and treatment response in migraine. Headache The Journal of Head and Face Pain. 63(2). 255–263. 3 indexed citations
8.
Zolin, Aryeh, et al.. (2023). Association of liver fibrosis with cognitive decline in Parkinson’s disease. Journal of Clinical Neuroscience. 119. 10–16. 5 indexed citations
9.
Barone, Daniel A., Harini Sarva, Fei Wang, et al.. (2023). Neurologic and psychiatric features of impending neurodegeneration in iRBD. Clinical Parkinsonism & Related Disorders. 9. 100216–100216. 1 indexed citations
10.
Siddiqui, Mustafa, Sol De Jesus, Harini Sarva, et al.. (2021). North American Survey on the Effects of the COVID-19 Pandemic Shutdown on DBS Care (2270). Neurology. 96(15_supplement). 2 indexed citations
12.
Rahman, Aneela, Eva Schelbaum, Eric A. Hoffman, et al.. (2020). Sex-driven modifiers of Alzheimer risk. Neurology. 95(2). e166–e178. 104 indexed citations
13.
Barone, Daniel A., Fei Wang, Lisa Ravdin, et al.. (2020). Comorbid neuropsychiatric and autonomic features in REM sleep behavior disorder. Clinical Parkinsonism & Related Disorders. 3. 100044–100044. 5 indexed citations
14.
Henchcliffe, Claire & Harini Sarva. (2020). Restoring Function to Dopaminergic Neurons: Progress in the Development of Cell-Based Therapies for Parkinson’s Disease. CNS Drugs. 34(6). 559–577. 6 indexed citations
15.
Cabrera, Laura Y., Harini Sarva, & Christos Sidiropoulos. (2019). Perspectives on the Earlier Use of Deep Brain Stimulation for Parkinson Disease from a Qualitative Study of U.S. Clinicians. World Neurosurgery. 128. e16–e20. 7 indexed citations
16.
Zhang, Xi, Jian Liang, Cao Xiao, et al.. (2019). Data-Driven Subtyping of Parkinson’s Disease Using Longitudinal Clinical Records: A Cohort Study. Scientific Reports. 9(1). 797–797. 87 indexed citations
17.
Sandrone, Stefano, Hani Kushlaf, Sneha Mantri, et al.. (2018). Neurologic and neuroscience education. Neurology. 92(4). 174–179. 21 indexed citations
18.
Sadoughi, Babak, et al.. (2017). A prospective crossover trial of botulinum toxin chemodenervation versus injection augmentation for essential voice tremor. The Laryngoscope. 128(2). 437–446. 13 indexed citations
19.
Sarva, Harini, et al.. (2016). Secondary orthostatic tremor in the setting of cerebellar degeneration. Journal of Clinical Neuroscience. 27. 173–175. 9 indexed citations
20.
Sarva, Harini & Kessarin Panichpisal. (2012). Gentamicin-induced Myoclonus. The Neurologist. 18(6). 385–388. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026